LLY
NYSEStockEli Lilly and Company
$977.73-21.95 (-2.20%)
52-Week Range
$625.65
$1109.94
Key Stats
Market Cap
922.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.43
Volume
1.5M
Avg Volume
2.8M
Performance
1M
-2.45%
3M
-2.69%
6M
+33.63%
YTD
-7.45%
1Y
+21.66%
3Y
+208.13%
5Y
+428.57%
Price Chart
ETF Exposure
LLY is held by 461 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IHE | iShares U.S. Pharmaceuticals ETF | 21.28% |
| MEDI | Harbor Health Care ETF (MEDI) | 19.86% |
| PPH | VanEck Pharmaceutical ETF | 18.80% |
| MEDX | Horizon Kinetics Medical ETF | 16.59% |
| OZEM | Roundhill Investments - GLP-1 & Weight Loss ETF | 16.28% |
| PBPH | Portfolio Building Block World Pharma and Biotech Index ETF | 15.01% |
| XLV | State Street Health Care Select Sector SPDR ETF | 14.35% |
| IYH | iShares U.S. Healthcare ETF | 14.05% |
| VHT | Vanguard Health Care ETF | 12.71% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 12.45% |
| THNR | Amplify Weight Loss Drug & Treatment ETF | 12.33% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 12.04% |
| RXL | ProShares - Ultra Health Care | 10.66% |
| IXJ | iShares Global Healthcare ETF | 10.09% |
| HRTS | Tema Cardiovascular and Metabolic ETF | 9.91% |
| GK | AdvisorShares Gerber Kawasaki ETF | 7.24% |
| JDOC | JPMorgan Healthcare Leaders ETF | 7.13% |
| PINK | Simplify Health Care ETF | 6.96% |
| ELIL | Direxion Daily LLY Bull 2X ETF | 5.94% |
| DRUP | GraniteShares Nasdaq Select Disruptors ETF | 5.72% |
| HDIV | QRAFT AI-Enhanced U.S. High Dividend ETF | 5.62% |
| LRND | NYLI U.S. Large Cap R&D Leaders ETF | 5.47% |
| SYE | SPDR MFS Systematic Core Equity ETF | 5.36% |
| PJP | Invesco Pharmaceuticals ETF | 5.04% |
| STXD | Strive 1000 Dividend Growth ETF | 4.95% |
| FLAG | Global X - S&P 500 U.S. Market Leaders Top 50 ETF | 4.86% |
| VGRO | Virtus Silvant Growth Opportunities ETF | 4.81% |
| MBCC | Monarch Blue Chips Core Index ETF | 4.72% |
| HART | NYLI Healthy Hearts ETF | 4.62% |
| DUHP | Dimensional - US High Profitability ETF | 4.49% |
| FTCE | First Trust New Constructs Core Earnings Leaders ETF | 4.28% |
| TOPT | iShares Top 20 U.S. Stocks ETF | 4.25% |
| HFGO | Hartford Large Cap Growth ETF | 4.24% |
| SNPG | Xtrackers S&P 500 Growth Scored & Screened ETF | 4.24% |
| BKCG | BNY Mellon Concentrated Growth ETF | 4.16% |
| CANC | Tema Oncology ETF | 4.14% |
| PGRO | Putnam Focused Large Cap Growth ETF | 4.12% |
| MNTL | Tema Neuroscience And Mental Health ETF | 4.05% |
| LNGR | Global X Aging Population ETF | 4.04% |
| FRIZ | Franklin Dividend Growth ETF | 4.03% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 4.01% |
| NUGO | Nuveen Growth Opportunities | 4.00% |
| XT | iShares Future Exponential Technologies ETF | 3.96% |
| ILDR | First Trust Innovation Leaders ETF | 3.94% |
| PJFG | PGIM Jennison Focused Growth ETF | 3.93% |
| GGRW | Gabelli Growth Innovators ETF | 3.92% |
| BAMG | Brookstone Growth Stock ETF | 3.92% |
| RND | First Trust Bloomberg R&D Leaders ETF | 3.91% |
| AVIE | Avantis Inflation Focused Equity ETF | 3.85% |
| LRNZ | TRUESHARES TECHNOLOGY, AI & DEEP LEARNING ETF | 3.84% |
Page 1 of 10Next
About LLY ETF Exposure
Eli Lilly and Company (LLY) is held by 461 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 922.3B, LLY is a widely held institutional stock. The stock currently trades at $977.73. Investors can gain exposure to LLY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LLY, sorted by portfolio weight.